Michelle L. Vandertie serves as Executive at Conatus Pharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, Michelle L. Vandertie has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 30, 2017 involved gifting 2,165 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| May 30, 2017 | CNAT | $0 | Gift | 2,165 | $N/A | Discretionary |
Michelle L. Vandertie currently holds 2,813 shares of Conatus Pharmaceuticals Inc. (CNAT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michelle L. Vandertie has been a net neutral trader of CNAT stock. They have purchased $0 and sold $0 worth of shares.
Michelle L. Vandertie's most recent insider trade was on May 30, 2017, when they sold 2,165 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted